ARTICLE
28 March 2012

European Medtech Announces Conference Vetting Ethicalmedtech To Go Live

CC
CMS Cameron McKenna Nabarro Olswang

Contributor

CMS is a Future Facing firm with 79 offices in over 40 countries and more than 5,000 lawyers globally. Combining local market insight with a global perspective, CMS provides business-focused advice to help clients navigate change confidently. The firm's expertise and innovative approach anticipate challenges and develop solutions. CMS is committed to diversity, inclusivity, and corporate social responsibility, fostering a supportive culture. The firm addresses key client concerns like efficiency and regulatory challenges through services like Law-Now, offering real-time eAlerts, mobile access, an extensive legal archive, specialist zones, and global events.

On 21 March 2012, the independent Compliance Panel of the European medical technology industry association Eucomed ("Eucomed") announced the launch of its EthicalMedtech platform for its conference vetting system ("EthicalMedtech") to go live.
European Union Food, Drugs, Healthcare, Life Sciences

On 21 March 2012, the independent Compliance Panel of the European medical technology industry association Eucomed ("Eucomed") announced the launch of its EthicalMedtech platform for its conference vetting system ("EthicalMedtech") to go live. The newly established independent EthicalMedtech system reviews and approves the compliance of third-party organized European educational conferences with the Eucomed Code of Ethical Business Practice ("Code").

According to Section III of the Code, Eucomed members may support third party-organized bona fide independent, education, scientific or policy-making conferences promoting scientific knowledge and medical advancement for healthcare professionals.

The new platform – the pilot phase of which is expected to last for around 6 months – serves the following major goals:

  • centralizing and simplifying the decision-making system for Eucomed members; and
    " harmonizing the interpretation of the Code throughout Europe so as to achieve greater transparency and consistency within the sector.
  • Consequently, should a stakeholder (e.g. a Eucomed member or a congress organiser) intend to sponsor or organise a relevant conference, it can submit the conference via the platform for assessment by the independent Compliance Officer. The deadline for the submission is no later than 90 days before the start of the conference. An expedited procedure is available on an exceptional basis and at the discretion of the Eucomed Compliance Panel. However, it is recommended that submissions be made as early as possible.

The assessments will be made by the independent Eucomed Compliance Officer who manages the procedure, assesses conferences and reports to the likewise independent Eucomed Compliance Panel.

As EthicalMedtech is currently in a pilot phase, the assessment rulings and the decisions by the Eucomed Compliance Officer are recommendations only and are not binding upon Eucomed members. Once the pilot phase is completed, the assessments will be binding on Eucomed members.

For more information please click here to see the press release.

The pilot EthicalMedtech platform is available here.

This article was written for Law-Now, CMS Cameron McKenna's free online information service. To register for Law-Now, please go to www.law-now.com/law-now/mondaq

Law-Now information is for general purposes and guidance only. The information and opinions expressed in all Law-Now articles are not necessarily comprehensive and do not purport to give professional or legal advice. All Law-Now information relates to circumstances prevailing at the date of its original publication and may not have been updated to reflect subsequent developments.

The original publication date for this article was 22/03/2012.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More